The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Haagenson, C. (1971) · Cited by 1,773
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Soy intake and cancer risk: A review of the in vitro and in vivo data
Messina, M. J., Persky, V., Setchell, K. D. R., & Barnes, S. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514310 · Cited by 1,315
Shepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Suppression of ICE and Apoptosis in Mammary Epithelial Cells by Extracellular Matrix
Boudreau, N., Sympson, C. J., Werb, Z., & Bissell, M. J. (1995) · Science · doi:10.1126/science.7531366 · Cited by 1,175
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., & Gronemeyer, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00736.x · Cited by 1,079
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Powles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
TRUSS, M., & BEATO, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 741
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
Cole, M. P., Jones, C. T. A., & Todd, I. D. H. (1971) · British Journal of Cancer · doi:10.1038/bjc.1971.33 · Cited by 701
Xu, J., Qiu, Y., DeMayo, F. J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1998) · Science · doi:10.1126/science.279.5358.1922 · Cited by 684
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660 · cited 1×
“Expression of the corepressor N-CoR is lower in TAM-stimulated MCF-7 xenografts than in wildtype xenografts (Lavinsky et al., 1998), but the functional relevance of the observation in human cancers is unclear.”
BackgroundBRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648
Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells
MARTIN, P. M., HORWITZ, K. B., RYAN, D. S., & McGUIRE, W. L. (1978) · Endocrinology · doi:10.1210/endo-103-5-1860 · Cited by 601
Pettersson, K., Grandien, K., Kuiper, G. G. J. M., & Gustafsson, J.-A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.10.9989 · Cited by 597
Konecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588
Phytoestrogens: epidemiology and a possible role in cancer protection.
Adlercreutz, H. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7103 · Cited by 553
Nucleophosmin regulates the stability and transcriptional activity of p53
Colombo, E., Marine, J.-C., Danovi, D., Falini, B., & Pelicci, P. G. (2002) · Nature Cell Biology · doi:10.1038/ncb814 · Cited by 528
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Bowers, J. L., Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7721 · Cited by 526
An essential role in liver development for transcription factor XBP-1
Reimold, A. M., Etkin, A., Clauss, I., Perkins, A., Friend, D. S., Zhang, J., Horton, H. F., Scott, A., Orkin, S. H., Byrne, M. C., et al. (2000) · Genes & Development · doi:10.1101/gad.14.2.152 · Cited by 516
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Molecular effects of genistein on estrogen receptor mediated pathways
Wang, T. T. Y., Sathyamoorthy, N., & Phang, J. M. (1996) · Carcinogenesis · doi:10.1093/carcin/17.2.271 · Cited by 489
Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Dauvois, S., Danielian, P. S., White, R., & Parker, M. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4037 · Cited by 465
Zava, D. T., & Duwe, G. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514498 · Cited by 462
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerham, D. L., & Fisher, B. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2659 · Cited by 438
Yang, N. N., Venugopalan, M., Hardikar, S., & Glasebrook, A. (1996) · Science · doi:10.1126/science.273.5279.1222 · Cited by 429
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Self-citationSmith, C. L., Oñate, S. A., Tsai, M. J., & O'Malley, B. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8884 · Cited by 414
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 414
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Buzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2000 · Cited by 406
The role of mitogen-activated protein (MAP) kinase in breast cancer
Santen, R. J., Song, R. X., McPherson, R., Kumar, R., Adam, L., Jeng, M.-H., & Yue, W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00189-3 · Cited by 406
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Barton, D. L., Loprinzi, C. L., Quella, S. K., Sloan, J. A., Veeder, M. H., Egner, J. R., Fidler, P., Stella, P. J., Swan, D. K., Vaught, N. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.495 · Cited by 403
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397 · cited 1×
“IRF-1 :NFkB heterodimers affect expression of the ATF-2/jun (Escalante et al., 1998), RANTES (Lee et al., 2000), VCAM-1 (Neish et al., 1995), IL-6 (Sanceau et al., 1995), and MHC class 1 genes (Drew et al., 1995).”
BackgroundActivation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
and members of the Southeast Sweden Breast Cancer Group, Pérez-Tenorio, G., & Stål, O. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600126 · Cited by 394
Growth Factors in Breast Cancer
DICKSON, R. B., & LIPPMAN, M. E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-5-559 · Cited by 388
ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells
Lazennec, G., Bresson, D., Lucas, A., Chauveau, C., & Vignon, F. (2001) · Endocrinology · doi:10.1210/endo.142.9.8395 · Cited by 380
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., & Isola, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2584 · Cited by 358
Minireview: Nuclear Receptor Coactivators--An Update
McKenna, N. J., & O’Malley, B. W. (2002) · Endocrinology · doi:10.1210/en.143.7.2461 · Cited by 356
Ross C., S., Yu Chen, C., Muralee G., N., & William G., H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.2.263 · Cited by 355
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 355
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 351
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
Howell, A., DeFriend, D. J., Blamey, R. W., Robertson, J. F., & Walton, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91156-1 · Cited by 349
Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase
Peter, M., Nakagawa, J., Dorée, M., Labbé, J. C., & Nigg, E. A. (1990) · Cell · doi:10.1016/0092-8674(90)90093-t · Cited by 345
Liao, D. J., & Dickson, R. B. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070143 · Cited by 343
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., & Taniguchi, T. (1996) · Nature · doi:10.1038/382816a0 · Cited by 324
Neish, A. S., Read, M. A., Thanos, D., Pine, R., Maniatis, T., & Collins, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2558 · Cited by 298
Patel, N. M., Nozaki, S., Shortle, N. H., Bhat-Nakshatri, P., Newton, T. R., Rice, S., Gelfanov, V., Boswell, S. H., Goulet, R. J., Sledge, G. W., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203768 · Cited by 294
Agarwal, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00385-3 · Cited by 280
Hilakivi-Clarke, L., Clarke, R., Onojafe, I., Raygada, M., Cho, E., & Lippman, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9372 · Cited by 261
Self-citationMcMichael-Phillips, D. F., Harding, C., Morton, M., Roberts, S. A., Howell, A., Potten, C. S., & Bundred, N. J. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1431s · Cited by 241
Breast cancer: cause and prevention
Hulka, B. S., & Stark, A. T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92713-1 · Cited by 239
Huang, R. P., Fan, Y., de Belle, I., Niemeyer, C. C., Gottardis, M. M., Mercola, D., & Adamson, E. D. (1997) · International Journal of Cancer · Cited by 237
Martin, M. B., Franke, T. F., Stoica, G. E., Chambon, P., Katzenellenbogen, B. S., Stoica, B. A., McLemore, M. S., Olivo, S. E., & Stoica, A. (2000) · Endocrinology · doi:10.1210/endo.141.12.7836 · Cited by 231
The proto-oncogene c-myc in hematopoietic development and leukemogenesis
Hoffman, B., Amanullah, A., Shafarenko, M., & Liebermann, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205400 · Cited by 228
Tokuyama, Y., Horn, H. F., Kawamura, K., Tarapore, P., & Fukasawa, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100014200 · Cited by 227
Aberrant function of the Ras signal transduction pathway in human breast cancer
Clark, G. J., & Der, C. J. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694753 · Cited by 213
Sancéau, J., Kaisho, T., Hirano, T., & Wietzerbin, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27920 · Cited by 212
Castro-Rivera, E., Samudio, I., & Safe, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103339200 · Cited by 211
Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo
Schiff, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1926 · Cited by 211
Nuclear factor-κB, cancer, and apoptosis
Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., & Merville, M.-P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00391-9 · Cited by 211
A hierarchical latent variable model for data visualization
Bishop, C. M., & Tipping, M. E. (1998) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/34.667885 · Cited by 201
Winer, E. P., Hudis, C., Burstein, H. J., Chlebowski, R. T., Ingle, J. N., Edge, S. B., Mamounas, E. P., Gralow, J., Goldstein, L. J., Pritchard, K. I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.020 · Cited by 200
Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A., Lipkus, I., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197
Adverse events reported by postmenopausal women in controlled trials with raloxifene
Davies, G. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00476-1 · Cited by 195
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
Encarnaci�n, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., & Osborne, C. K. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665801 · Cited by 194
Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy
Kent Osborne, C., Coronado, E. B., & Robinson, J. P. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90154-4 · Cited by 187
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
Hilakivi-Clarke, L., Onojafe, I., Raygada, M., Cho, E., Skaar, T., Russo, I., & Clarke, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690584 · Cited by 186
Self-citationCollins, B. M., McLachlan, J. A., & Arnold, S. F. (1997) · Steroids · doi:10.1016/s0039-128x(96)00246-2 · Cited by 183
Delgado, M., Muñoz‐Elías, E. J., Gomariz, R. P., & Ganea, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4685 · Cited by 181
The Scottish Cancer Trials Breast Group, Stewart, H., Forrest, A., Everington, D., McDonald, C., Dewar, J., Hawkins, R., Prescott, R., & George, W. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.356 · Cited by 177
Kondo, T., Minamino, N., Nagamura-Inoue, T., Matsumoto, M., Taniguchi, T., & Tanaka, N. (1997) · Oncogene · doi:10.1038/sj.onc.1201286 · Cited by 177
Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.
Love, R. R. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.6.803 · Cited by 170
EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA
Nozawa, Y., van Belzen, N., MADE, A. C. J. V. D., Dinjens, W. N. M., & Bosman, F. T. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199601)178:1<48::aid-path432>3.0.co;2-y · Cited by 169
CLARKE, S. D., GASPERIKOVA, D., NELSON, C., LAPILLONNE, A., & HEIRD, W. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04284.x · Cited by 167
Tamoxifen: A Reappraisal of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use
Buckley, M. M.-T., & Goa, K. L. (1989) · Drugs · doi:10.2165/00003495-198937040-00004 · Cited by 167
Protein Kinase Inhibition by ω-3 Fatty Acids
Mirnikjoo, B., Brown, S. E., Kim, H. F. S., Marangell, L. B., Sweatt, J. D., & Weeber, E. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008150200 · Cited by 166
Gundimeda, U., Chen, Z.-H., & Gopalakrishna, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13504 · Cited by 165
Genistein: does it prevent or promote breast cancer?
Bouker, K. B., & Hilakivi-Clarke, L. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108701 · Cited by 160
Self-citationActivation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
Kim, D. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.871 · Cited by 160
Montano, M. M., & Katzenellenbogen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2581 · Cited by 159
Nicholson, R. I., Hutcheson, I. R., Harper, M. E., Knowlden, J. M., Barrow, D., McClelland, R. A., Jones, H. E., Wakeling, A. E., & Gee, J. M. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080175 · Cited by 159
The ribonuclease activity of nucleolar protein B23
Herrera, J. E., Savkur, R. S., & Olson, M. O. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3974 · Cited by 158
Suk, K., Chang, I., Kim, Y., Kim, S., Kim, J., Kim, H., & Lee, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007646200 · Cited by 152
Veronesi, U., Maisonneuve, P., Rotmensz, N., Costa, A., Sacchini, V., Travaglini, R., D’Aiuto, G., Lovison, F., Gucciardo, G., Muraca, M. G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.160 · Cited by 152
The ligand binding profiles of estrogen receptors α and β are species dependent
Harris, H. A., Bapat, A. R., Gonder, D. S., & Frail, D. E. (2002) · Steroids · doi:10.1016/s0039-128x(01)00194-5 · Cited by 150
Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue
List, H.-J., Reiter, R., Singh, B., Wellstein, A., & Riegel, A. T. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1017910924390 · Cited by 148
Molecular and pharmacological aspects of antiestrogen resistance
Clarke, R. C., Skaar, T. C., Bouker, K. B., Davis, N., Lee, Y. R., Welch, J. N., & Leonessa, F. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00193-x · Cited by 144
Self-citationFreedman, M. T., Martin, J. S., O'Gorman, J. T., Eckert, S., Lippman, M. E., Lo, S.-C. B., Walls, E. L., & Zeng, J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.51 · Cited by 143
Tamoxifen Flare in Advanced Breast Cancer
Plotkin, D. (1978) · JAMA · doi:10.1001/jama.1978.03290240044022 · Cited by 142
Molecular Cloning of an Estrogen Receptor β Subtype from the Goldfish,Carassius auratus
Tchoudakova, A., Pathak, S., & Callard, G. V. (1999) · General and Comparative Endocrinology · doi:10.1006/gcen.1998.7217 · Cited by 136
Serum concentration of tumor necrosis factor in patients with breast cancer
Sheen‐Chen, S., Chen, W., Eng, H., & Chou, F. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005736712307 · Cited by 132
Sancéau, J., Hiscott, J. B., Delattre, O., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203670 · Cited by 132
Drew, P. D., Franzoso, G., Becker, K. G., Bours, V., Carlson, L. M., Siebenlist, U. K., & OZATO, K. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.1037 · Cited by 129
Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study
Schairer, C., Gail, M. H., Byrne, C., Rosenberg, P. S., Sturgeon, S. R., Brinton, L. A., & Hoover, R. N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.264 · Cited by 124
Nozawa, H., Oda, E., Nakao, K., Ishihara, M., Ueda, S., Yokochi, T., Ogasawara, K., Nakatsuru, Y., SHIMIZU, S., Ohira, Y., et al. (1999) · Genes & Development · doi:10.1101/gad.13.10.1240 · Cited by 123
Friedrich, K., Wieder, T., von Haefen, C., Radetzki, S., Jänicke, R. U., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204342 · Cited by 122
Inouye, C. J., & Seto, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37400-8 · Cited by 121
Potential Role of Dietary Isoflavones in the Prevention of Cancer
Barnes, S., Peterson, G., Grubbs, C. J., & Setchell, K. D. R. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0939-8_10 · Cited by 120
The nucleic acid binding activity of nucleolar protein B23.1 resides in its carboxyl-terminal end.
Wang, D., Baumann, A. P., Szebeni, A., & Olson, M. O. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47380-2 · Cited by 119
Atanaskova, N., Keshamouni, V. G., Krueger, J. S., Schwartz, J. A., Miller, F. W., & Reddy, K. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205506 · Cited by 116
Inhibition of the RelA(p65) NF-κB Subunit by Egr-1
Chapman, N., & Perkins, N. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4719 · Cited by 115
Kim, M. Y., Hsiao, S. J., & Kraus, W. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6084 · Cited by 112
Kinsinger, L., Harris, R., Woolf, S. H., Sox, H. C., & Lohr, K. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00017 · Cited by 112
Vascular effects of estrogen and vitamin E therapies in postmenopausal women.
Koh, K., Blum, A., Hathaway, L., Mincemoyer, R., Csako, G., Waclawiw, M., Panza, J., & Cannon, R. (1999) · Circulation · doi:10.1161/01.cir.100.18.1851 · Cited by 111
Reduction of the Membrane Fluidity of Human Breast Cancer Cells by Tamoxifen and 17beta-Estradiol
Clarke, R. C., van den Berg, H. W., & Murphy, R. F. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.21.1702 · Cited by 110
Self-citationCLAUSS, I. M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.10.1855 · Cited by 108
Ahn Hwee, L. E. E., Hong, J., & Seo, Y. (2000) · Biochemical Journal · doi:10.1042/bj3500131 · Cited by 103
Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1542 · Cited by 100
Reiter, R., Wellstein, A., & Riegel, A. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104744200 · Cited by 94
Smith, C. S., DeVera, D. G., Lamb, D. J., Nawaz, Z., Jiang, Y., Beaudet, A. L., & O’Malley, B. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.525-535.2002 · Cited by 92
The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells
Chow, W. A., Fang, J., & Yee, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3512 · Cited by 90
Antioestrogens in the management of hormone-dependent cancer
Litherland, S. A., & Jackson, I. M. (1988) · Cancer Treatment Reviews · doi:10.1016/0305-7372(88)90002-3 · Cited by 83
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity
deGraffenried, L. A., Friedrichs, W. E., Fulcher, L. C., Fernandes, G., Silva-Fisher, J., Peralba, J.-M., & Hidalgo, M. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg291 · Cited by 81
Nuclear receptors, coactivators and chromatin: new approaches, new insights
Lee, K. C., & Kraus, W. L. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00392-7 · Cited by 80
Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
Tanaka, N., Ishihara, M., & Taniguchi, T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90318-2 · Cited by 80
Oestrogen receptor β in breast cancer: good, bad or still too early to tell?
Speirs, V. (2002) · The Journal of Pathology · doi:10.1002/path.1072 · Cited by 80
Multifunctional Aspects of the Action of Indole‐3‐Carbinol as an Antitumor Agent
Bradlow, H. L., Sepkovic, D. W., TELANG, N. T., & Osborne, M. P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08736.x · Cited by 79
Interferon Regulatory Factor Expression in Human Breast Cancer
Doherty, G. M., Boucher, L. D., Sorenson, K., & Lowney, J. K. (2001) · Annals of Surgery · doi:10.1097/00000658-200105000-00005 · Cited by 71
Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2
Coccia, E. M., Russo, N. D., Stellacci, E., Orsatti, R., Benedetti, E., Marziali, G., Hiscott, J. B., & Battistini, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202536 · Cited by 68
Suppression by estrogen receptor β of AP-1 mediated transactivation through estrogen receptor α
Maruyama, S., Fujimoto, N., Asano, K., & Ito, A. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00083-8 · Cited by 67
Tamoxifen metabolism: pharmacokinetic and in vitro study
Étienne-Grimaldi, M.-C., Milano, G. A., Fischel, J.-L., Frénay, M., François, É., Formento, J. L., Gioanni, J., & Namer, M. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.214 · Cited by 67
Diet and cancer : markers, prevention, and treatment
Jacobs, M. M., & Markers, P. C. (1994) · Medical Entomology and Zoology · Cited by 66
Molino, A., Micciolo, R., Turazza, M., Bonetti, F., Piubello, Q., Corgnati, A., Sperotto, L., Recaldin, E., Spagnolli, R., Manfrin, E., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005769925670 · Cited by 66
Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies
Saunders, P. T. K., Millar, M. R., Williams, K., Macpherson, S., Bayne, C. W., O'Sullivan, C., Anderson, T. J., Groome, N. P., & Miller, W. R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600035 · Cited by 66
Hopp, T. A., & Fuqua, S. A. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018726418931 · Cited by 65
Do estrogens always increase breast cancer risk?
Hilakivi-Clarke, L. A., Cabanes, A., Olivo, S. E., Kerr, L., Bouker, K. B., & Clarke, R. C. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00184-4 · Cited by 64
Self-citationDas, A., Damodaran, C., Dey, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008454200 · Cited by 60
Wurtz, J., Egner, U., Heinrich, N., Moras, D., & Mueller‐Fahrnow, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970406v · Cited by 59
The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins
Berger, T., Brigl, M., Herrmann, J. M., Vielhauer, V., Luckow, B., Schlöndorff, D., & Kretzler, M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3603 · Cited by 58
The pathophysiological role of estrogen receptor variants in human breast cancer
Murphy, L. C., Dotzlaw, H., Leygue, E., Coutts, A. S., & Watson, P. H. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00012-0 · Cited by 58
Effect of P-glycoprotein Expression on Sensitivity to Hormones in MCF-7 Human Breast Cancer Cells
Clarke, R. C., Currier, S., Kaplan, O., Lovelace, E., Boulay, V., Gottesman, M. M., & Dickson, R. B. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1506 · Cited by 57
Self-citationClarke, R. C., Brünner, N., Thompson, E. W., Glanz, P., Katz, D. A., Dickson, R. B., & Lippman, M. E. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1220331 · Cited by 56
Self-citationThoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?
Graham, J. D., Bain, D. L., Richer, J. K., Jackson, T. A., Tung, L. W., & Horwitz, K. B. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00101-1 · Cited by 55
NF-kappaB and Apoptosis in Mammary Epithelial Cells
Clarkson, R. W. E., & Watson, C. J. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018725207969 · Cited by 51
Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer
Joensuu, H., Holli, K., Oksanen, H. M., & Valavaara, R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006465732143 · Cited by 51
Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00250-1 · Cited by 50
Sers, C., Husmann, K., Nazarenko, I. A., Reich, S., Wiechen, K., Zhumabayeva, B., Adhikari, P., Schröder, K., Gontarewicz, A., & Schäfer, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205377 · Cited by 50
Biswas, D. K., Reddy, P. V., Pickard, M., Makkad, B., Pettit, N., & Pardee, A. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33817 · Cited by 48
Transcription factors IRF-1 and IRF-2: Linking the immune responses and tumor suppression
Taniguchi, T. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<128::aid-jcp8>3.0.co;2-p · Cited by 45
NFκB activation is required for interferon regulatory factor‐1‐mediated interferon β induction
Kirchhoff, S., Wilhelm, D., Angel, P. E., & Häuser, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00308.x · Cited by 44
Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene
Contente, S., Kenyon, K., Sriraman, P., Subramanyan, S., & Friedman, R. M. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006913122261 · Cited by 42
Tebar, F., Lladó, A., & Enrich, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02624-8 · Cited by 42
Fattman, C. L., An, B., Sussman, L., & Dou, Q. P. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00121-9 · Cited by 42
Molecular forms of the estrogen receptor in breast cancer
Leclercq, G. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00026-2 · Cited by 40
Rowlands, M., Budworth, J., Jarman, M., Hardcastle, I. R., McCague, R., & Gescher, A. J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00186-4 · Cited by 36
Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients.
Brankin, B., Skaar, T. C., Brotzman, M. J., Trock, B. J., & Clarke, R. C. (1998) · PubMed · Cited by 36
Self-citationAssociation of steroid receptor coactivator AIB1 with estrogen receptor-α in breast cancer cells
Azorsa, D. O., Cunliffe, H. E., & Meltzer, P. S. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1012972808558 · Cited by 35
Future uses for aromatase inhibitors in breast cancer
Dowsett, M. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80021-0 · Cited by 29
Egeblad, M., & Jäättelä, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<617::aid-ijc3>3.0.co;2-z · Cited by 29
The Egr-1 gene is induced by epidermal growth factor in ECV304 cells and primary endothelial cells
Tsai, J. C., Liu, L., Guan, J., & Aird, W. C. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1414 · Cited by 27
Kyprianou, N., MARTIKAINEN, P. M., & Isaacs, J. T. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3704-5_4 · Cited by 26
Kenny, F. S., Gee, J. M. W., Nicholson, R. I., Ellis, I. O., Morris, T. M., Watson, S. A., Bryce, R. P., & Robertson, J. F. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1213 · Cited by 24
Are the Effects of Tamoxifen on the Serum Lipid Profile Modified by Apolipoprotein E Phenotypes?
Liberopoulos, E. N., Karabina, S.-A. P., Tselepis, A. D., Bairaktari, E. T., Nicolaides, C., Pavlidis, N., & Elisaf, M. (2002) · Oncology · doi:10.1159/000048256 · Cited by 24
Mori, K., Stone, S., Khaodhiar, L., Braverman, L. E., & DeVito, W. J. (1999) · PubMed · Cited by 23
Interaction of unsaturated fatty acids with anti-oestrogen-binding sites
Hwang, P. L. H. (1987) · Biochemical Journal · doi:10.1042/bj2430359 · Cited by 23
MILLER, M. A., Greene, G. L., & Katzenellenbogen, B. S. (1984) · Endocrinology · doi:10.1210/endo-114-1-296 · Cited by 21
Activation of the Human p27Kip1 Promoter by IFNα 2b
Moro, A., Santos, A., Araña, M. J., & Perea, S. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2256 · Cited by 19
Mori, K., Stone, S., Khaodhiar, L., Braverman, L. E., & DeVito, W. J. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990801)74:2<211::aid-jcb7>3.0.co;2-u · Cited by 18
Lilling, G., Nordenberg, J., Rotter, V., Goldfinger, N., Peller, S., & Sidi, Y. (2002) · Cancer Investigation · doi:10.1081/cnv-120002151 · Cited by 16
Varley, C. L., & Dickson, A. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1431 · Cited by 8
Hodson, J. D. (1983) · Springer eBooks · doi:10.1007/978-94-009-7257-5_4 · Cited by 4
Magnusson (1999) · doi:10.1002/(sici)1097-0215(19990505)81:3<339::aid-ijc5>3.0.co;2-6
Cited by
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Ma, X.-J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.015 · Cited by 954
Jin, Y., Desta, Z., Stearns, V., Ward, B., Ho, H., Lee, K.-H., Skaar, T., Storniolo, A. M., Li, L., Araba, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji005 · Cited by 951
Self-citation
Metadata
- Authors
- Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O'Brien, K., Wang, Y., & Hilakivi-Clarke, L. A.
- Venue
- Oncogene
- Published
- 2003-10-20
- Volume
- 22
- Issue
- 47
- Pages
- 7316-7339
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2013145602
- Cited by
- 478
- References
- 197
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.